Browse

Explore conditions, clinical trials, and the organisations running them.

Up to: Diazoxide-sensitive diffuse hyperinsulinism

Hyperinsulinism due to HNF1A deficiency

Hyperinsulinism due to HNF1A deficiency is a form of diazoxide-sensitive diffuse hyperinsulinism (DHI), characterized by transient or persistent hyperinsulinemic hypoglycemia (HH) in infancy that is responsive to diazoxide, evolving in to maturity-onset diabetes of the young subtype 1 (MODY-1) later in life.

0 trials tagged with this condition →

This condition has no sub-types.